Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Targeting mitochondrial vulnerabilities in multiple myeloma

Simone Cenci • 26 Aug 2022
IMS 2022
Multiple Myeloma

Simone Cenci, MD, IRCCS Ospedale San Raffaele, Milan, Italy, discusses the role of mitochondrial vulnerabilities in multiple myeloma, highlighting the possibility of targeting those vulnerabilities to selectively inhibit multiple myeloma cells. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Simone Cenci

1:51
The role of ER-phagy in multiple myeloma cell survival
Simone Cenci • 26 Aug 2022

Related Videos

1:33
Post-hoc analysis of TOURMALINE-MM1 data while adjusting for subsequent therapies
Karthik Ramasamy • 28 Apr 2024
3:05
The development of iNKT-CAR T-cells for hematological malignancies
Kanagaraju Ponnusamy • 29 Apr 2024
4:24
Investigating production failure and out-of-specification production of CAR T-cell therapeutics
Nina Worel • 25 Apr 2024
1:14
Using MRD to accelerate drug approval in multiple myeloma
Karthik Ramasamy • 28 Apr 2024
The content of VJHemOnc is intended for healthcare professionals